Moreover, both in vitro and in vivo studies have suggested that increased USP22 (ubiquitin-specific peptidase 22) expression in CSCs derived from CRC is responsible for resistance to 5-FU due to the induction of the Wnt/β-catenin pathway [245]. Here, USP22 is linked to colorectal carcinoma.